[P. Loiseau, Rational use of valproate: Indications and drug regimen in epilepsy, Epilepsy 25 (1984) 65-72; DOI: 10.1111/j.1528-1157.1984.tb05641.x.10.1111/j.1528-1157.1984.tb05641.x]Search in Google Scholar
[O. Dulac, D. Steru, E. Rey and M. Arthius, Sodium valproate monotherapy in childhood epilepsy, Brain Dev. 8 (1986) 47-52.10.1016/S0387-7604(86)80119-X]Search in Google Scholar
[D. C. Lagacea, W. T. O'Brienb, N. Gurvichb, M. W. Nachtigala and P. S. Klein, Valproic acid: How it works. Or not, Clin. Neurosci. Res. 4 (2004) 215-225; DOI: 10.1016/j.cnr.2004.09.013.10.1016/j.cnr.2004.09.013]Search in Google Scholar
[P. Wal, B. Kumar, A. Bhandari, A. K. Rai and A. Wal, Bioanalytical method development - Determination of drugs in biological fluids, J. Pharm. Sci. Tech. 2 (2010) 333-347.]Search in Google Scholar
[S. I. Johannessen, Therapeutic Drug Monitoring of Antiepileptic Drugs, in Drug Monitoring and Clinical Chemistry (Ed. G. Hempel) in Elsevier, Amsterdan 2004, in (Ed. R. M. Smith) Handbook of Analytical Separation. Vol. 5, pp. 221-253; DOI: 10.1016/S1567-7192(04)80010-X.10.1016/S1567-7192(04)80010-X]Search in Google Scholar
[P. N. Patsalos, D. J. Berry, B. F. D. Bourgeois, J. C. Cloyd, T. A. Glauser, S. I. Johannessen, I. E. Leppik, T. Tomson and E. P. Patsalos, Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on the therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies, Epilepsia (2008) 1-38; DOI: 10.1111/j.1528-1167.2008.01561.x.10.1111/j.1528-1167.2008.01561.x]Search in Google Scholar
[S. J. Soldin, Free drug measurement, Arch. Pathol. Lab. Med. 123 (1999) 822-823.10.5858/1999-123-0822-FDM]Search in Google Scholar
[H. Liu and M. R. Delgado, Therapeutic drug concentration monitoring using saliva samples, Clin. Pharmacokin. 36 (1999) 453-470; DOI: 10.2165/00003088-199936060-00006.10.2165/00003088-199936060-00006]Search in Google Scholar
[H. S. Chung, T. L. Seung and L. Soo-Youn, Evaluation of Viva-E drug testing system, Korean J. Lab. Med. 27 (2007) 330-337; DOI: 10.3343/kjlm.2007.27.5.330.10.3343/kjlm.2007.27.5.330]Search in Google Scholar
[R. L. Dills and D. D. Shen, Methods to reduce background interferences in electron-capture gas chromathographic analysis of valproic acid and its unsaturated metabolites after derivatization with pentafluorobenzyl bromide, J. Chromatogr. B Biomed. Appl. 690 (1997) 139-152; DOI: 10.1016/S0378-4347(96)00405-7.10.1016/S0378-4347(96)00405-7]Search in Google Scholar
[S. Rompotis, M. Parissi-Poulou, E. Gikas, M. Kazanis, A. Vavayannis and I. Panderi, Determination of valproic acid in human plasma by HPLC with fluorescence detection, J. Liq. Chromatogr. 25 (2002) 2833-2847; DOI: 10.1081/JLC-120014953.10.1081/JLC-120014953]Search in Google Scholar
[H. Amini, M. Javan and A. Ahmadiani, Development and validation of a sensitive assay of valproic acid in human plasma by high-performance liquid chromatography without prior derivatization, J. Chromatogr. B 830 (2006) 368-371; DOI: 10.1016/j.jchromb.2005.11.028.10.1016/j.jchromb.2005.11.02816324890]Search in Google Scholar
[D. S. Jain, G. Subbaiah, M. Sanyal and P. Shrivastav, A high through and selective method for the estimation of valproic acid an antiepileptic drug in human plasma by tandem LC-MS/MS, Talanta 72 (2007) 80-88.10.1016/j.talanta.2006.09.03319071585]Search in Google Scholar
[Guideline on validation of bioanalytical methods, European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP), London 2009; http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/12/WC500018062.pdf]Search in Google Scholar
[M. Krogh, K. Johansen, F. Tonnesen and K. E. Rasmussen, Solid-phase microextraction for the determination of the free concentration of valproic acid in human plasma by capillary gas chromatography, J. Chromatogr. B 673 (1995) 299-305; DOI: 10.1016/03784347(95)00273-8.]Search in Google Scholar